Literature DB >> 19833578

Sex and age differences in levothyroxine dosage requirement.

Jacqueline Jonklaas1.   

Abstract

OBJECTIVE: To examine the performance of weight-based formulae for estimating the levothyroxine dosage requirement in athyreotic patients and to determine whether formula performance is affected by age, sex, or menstrual status.
METHODS: In this prospective study, euthyroid study participants aged 18 to 65 years were followed up after total thyroidectomy at 4 time points: 6-8 weeks, 12-16 weeks, 6 months, and 1 year. Patient weight, serum thyrotropin concentration, and levothyroxine dosage required were recorded at each time point. The postoperative starting levothyroxine dosage was 1.7 mcg/kg daily for patients with benign thyroid disease and 2.2 mcg/kg daily for patients with thyroid cancer. Actual body weight was used to calculate the initial dosage. At steady state, adjustments were made in each patient's levothyroxine dosage until the target thyrotropin concentration was reached. The levothyroxine dosage required to achieve this goal was documented.
RESULTS: Fifty patients were included (37 women, 13 men). Formulae based on actual body weight were accurate in achieving a normal thyrotropin concentration in 48% to 75% of participants. Final dosages to achieve normal thyrotropin values were similar in men (1.43 mcg/kg daily) and menopausal women (1.68 mcg/kg daily), but higher in premenopausal women (2.10 mcg/kg daily). When a formula based on ideal body weight was used, the requirement for menopausal women (2.34 mcg/kg daily) was similar to that of premenopausal women (2.44 mcg/kg daily), but the requirement for men (1.73 mcg/kg daily) remained lower than that observed in both female groups.
CONCLUSIONS: When actual body weight was used to calculate levothyroxine dosage requirement, premenopausal women appeared to have a greater requirement than either menopausal women or men. When ideal weight was used, the requirement of all women was greater than that of men. Perhaps with formulae using actual weight, this apparent sex difference is masked by the greater weight, older age, or altered hormonal milieu of menopausal women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19833578     DOI: 10.4158/EP09257.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  22 in total

1.  Levothyroxine replacement doses are affected by gender and weight, but not age.

Authors:  Madhuri Devdhar; Rebecca Drooger; Marieta Pehlivanova; Gurdeep Singh; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2011-07-13       Impact factor: 6.568

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

3.  Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches.

Authors:  Marco Centanni
Journal:  Endocrine       Date:  2012-10-25       Impact factor: 3.633

4.  Age and the thyrotropin response to hypothyroxinemia.

Authors:  Rebecca Over; Sonia Mannan; Hala Nsouli-Maktabi; Kenneth D Burman; Jacqueline Jonklaas
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

Review 5.  The emergence of levothyroxine as a treatment for hypothyroidism.

Authors:  James V Hennessey
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

6.  The TRHR Gene Is Associated with Hypothalamo-Pituitary Sensitivity to Levothyroxine.

Authors:  Giulia Brigante; Giorgia Spaggiari; Daniele Santi; Katia Cioni; Valentina Gnarini; Chiara Diazzi; Elisa Pignatti; Livio Casarini; Marco Marino; Frank Tüttelmann; Cesare Carani; Manuela Simoni
Journal:  Eur Thyroid J       Date:  2014-06-07

7.  The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders.

Authors:  Chanjuan Ma; F Stephen Hodi; Anita Giobbie-Hurder; Xiaocheng Wang; Jing Zhou; Amy Zhang; Ying Zhou; Fei Mao; Trevor E Angell; Chelsea P Andrews; Jiani Hu; Romualdo Barroso-Sousa; Ursula B Kaiser; Sara M Tolaney; Le Min
Journal:  Cancer Immunol Res       Date:  2019-05-14       Impact factor: 11.151

8.  Stable Isotope Pharmacokinetic Studies Provide Insight into Effects of Age, Sex, and Weight on Levothyroxine Metabolism.

Authors:  Islam R Younis; Mariam A Ahmed; Kenneth D Burman; Offie P Soldin; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2018-01-02       Impact factor: 6.568

Review 9.  Thyroid hormone therapy for hypothyroidism.

Authors:  Bernadette Biondi; David S Cooper
Journal:  Endocrine       Date:  2019-08-01       Impact factor: 3.633

10.  Using body mass index to predict optimal thyroid dosing after thyroidectomy.

Authors:  Kristin A Ojomo; David F Schneider; Alexandra E Reiher; Ngan Lai; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  J Am Coll Surg       Date:  2013-01-11       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.